90% of all prescriptions filled, yet only 12% of the spending, affordable medicines face severe sustainability challenges in the U.S. WASHINGTON, DC (September 3, 2025) – The Association for Accessible Medicines and the Biosimilars Council today released the 2025 U.S. Generic & Biosimilar Medicines Savings Report. AAM’s annual savings report highlights that generic and biosimilar … Continue reading Generic and Biosimilar Medicines Save $467 Billion in 2024